Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Placental tissue shows promise for stubborn wounds

NCT ID NCT07215741

First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 32 times

Summary

This study looks back at medical records of 50 people with hard-to-heal wounds, like diabetic foot ulcers, who were treated with a placental membrane product called Relese. Researchers want to see how many wounds fully close within 12 weeks. The goal is to understand if this treatment works well in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC WOUNDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cypress Wound Care

    Oklahoma City, Oklahoma, 73103, United States

  • Premier Foot & Ankle

    Denison, Texas, 75020, United States

  • Premier Foot & Ankle

    Frisco, Texas, 75033, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

human placental membrane tissue (Relese)

What this could lead to

If successful, this could provide a better treatment option for people with chronic wounds that are difficult to heal.

What could go wrong

This is a small, retrospective study without a control group, so results may not prove effectiveness. The treatment may not work for everyone.

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.